The increasing number of novel tobacco products has prompted the agency to review its processes, procedures and leadership structure - Treatment Magazine

Work is poised to get underway on a somewhat rare internal review by the U.S. Food and Drug Administration (FDA) that could impact how the agency processes new tobacco products and enforces the sale of them by retailers.

Read more.